As sell-side analyst
Adeza |
IPO |
Cepheid |
Secondary offerings (2) |
Large Scale Biology |
IPO |
Sangamo Pharmaceuticals |
IPO |
Serologicals |
Secondary offering |
Threshold Pharmaceuticals |
IPO |
Other
Private diagnostic firm |
Assisted in funding by strategic partner |
Private life science firm |
Multiple bridge loans |